Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Adeshwar MeditexBOM:543309 63 ROE % is 2.81% as of Mar. 2026, which is 57% below its 10-year median of 6.50. GuruFocus rates BOM:543309 with a GF Score™ of 63/100 and a GF Value™ of ₹15.09 (Fairly Valued). The stock has 7 warning signs investors should review. Among 799 Medical Devices & Instruments companies, Adeshwar Meditex ranks better than 53.44% on this metric.
The historical rank and industry rank for Adeshwar Meditex's ROE % or its related term are showing as below:
BOM:543309'
s ROE % Range Over the Past 10 Years
Min: 3.08 Med: 6.5 Max: 18.9
Current: 3.36
During the past 9 years, Adeshwar Meditex's highest ROE % was 18.90%. The lowest was 3.08%. And the median was 6.50%.
BOM:543309's ROE % is ranked better than 53.44% of 799
companies
in the Medical Devices & Instruments industry
Industry Median: 2.42
vs BOM:543309: 3.36
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is two times the semi-annual (Mar. 2026) net income data. The Revenue data used here is two times the semi-annual (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Adeshwar Meditex ROE % Related Terms
Adeshwar Meditex ROE % Historical Data
* Premium members only.
The historical data trend for Adeshwar Meditex's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Adeshwar Meditex's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Adeshwar Meditex ROE % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Adeshwar Meditex's ROE % distribution charts can be found below:
* The bar in red indicates where Adeshwar Meditex's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Adeshwar Meditex (BOM:543309) has a ROE % of 2.81% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Adeshwar Meditex and its competitors. This is 57% below median its historical median of 6.50. Over the past decade, Adeshwar Meditex's ROE % has ranged from 3.08 to 18.90. According to the industry distribution chart, Adeshwar Meditex ranks #372 out of 799 companies in the Medical Devices & Instruments industry, placing it in the top 46.6%.
Is Adeshwar Meditex's ROE % too high?
Adeshwar Meditex's current ROE % of 2.81% is 57% below median its 10-year median of 6.50. Over the past 10 years, this metric has ranged from a low of 3.08 to a high of 18.90. The Medical Devices & Instruments industry median ROE % is 2.42. Adeshwar Meditex's value of 2.81% is 16.1% above this industry median. Based on the distribution chart, Adeshwar Meditex ranks #372 out of 799 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Adeshwar Meditex has a GF Score™ of 63/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Adeshwar Meditex's ROE % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Adeshwar Meditex ranks #372 out of 799 companies for ROE %. This puts Adeshwar Meditex in the upper half of its industry. The industry median ROE % is 2.42. Adeshwar Meditex's value of 2.81% is 16.1% above this benchmark. Historically, Adeshwar Meditex's own ROE % has ranged from 3.08 to 18.90 over the past decade. While the company's 10-year median is 6.50 vs. the industry median of 2.42, Adeshwar Meditex has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Medical Devices & Instruments company?
The median ROE % among Medical Devices & Instruments companies is 2.42, based on 799 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Adeshwar Meditex's current ROE % of 2.81% is 16.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Adeshwar Meditex and its competitors. For the Medical Devices & Instruments industry, the median ROE % is 2.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Adeshwar Meditex's current ROE % is 2.81%, which is 57% below median its own 10-year median of 6.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adeshwar Meditex stock overvalued right now?
Based on GuruFocus' analysis, Adeshwar Meditex (BOM:543309) is currently considered Fairly Valued. The stock's GF Value™ is ₹15.09, compared to a current price of ₹16.30 — trading 8% above its estimated fair value. The current ROE % is 2.81%, which is 57% below median its 10-year median of 6.50 and 16.1% above the Medical Devices & Instruments industry median of 2.42. Adeshwar Meditex's overall GF Score™ is 63/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Adeshwar Meditex (BOM:543309), the current ROE % is 2.81% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Adeshwar Meditex (BOM:543309) Overvalued in 2026?
Based on GuruFocus' analysis, Adeshwar Meditex stock appears to be overvalued.
The current stock price of ₹16.30 is trading 8% above its estimated GF Value™ of ₹15.09.
GuruFocus considers Adeshwar Meditex to be Fairly Valued.
Key valuation signals for BOM:543309:
ROE %: 2.81% (57% below median its 10-year median of 6.50)
GF Value™: ₹15.09 vs. price of ₹16.30 (8% above fair value)
Industry Position: 16.1% above the Medical Devices & Instruments median (#372 of 799)
No single metric tells the full story. See the BOM:543309 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Adeshwar Meditex Ltd is engaged in manufacturing surgical dressings and external preparations products such as Sterile surgical wound dressing, Combine dressing, Gauze Dressing and Cotton Products, Medical Bandages and Plaster, Antiseptics / Disinfectants, and others.
63GF Score
Get the complete analysis for BOM:543309
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543309 has been successfully added to your 
